Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

A Study of AK146D1 for Injection in the Treatment of Advanced Solid Tumors — Stella

Home/Advanced Solid Tumors/A Study of AK146D1 for Injection in the Treatment of Advanced Solid Tumors

View on ClinicalTrials.gov

Recruiting

Back to Advanced Solid Tumors trials

A Study of AK146D1 for Injection in the Treatment of Advanced Solid Tumors

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(1 site)

Australia

Scientia Clinical Research, Sydney, New South Wales

Key details

Phase

Early testing

Sponsor

Akeso

Enrollment target

~48 participants

Started

July 2025

Primary completion

November 2026

Age range

18 Years – 75 Years

Last updated July 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.